Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HAAO | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF333 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ANO4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SUGT1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | PCDHA4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ZBTB39 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | STARD9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | PPP1R13B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ZNF254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | OAT | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |